Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Post by Mt69sinaion Jan 10, 2022 8:34am
347 Views
Post# 34299168

Piper Sandler on Tilray Q2; Canada Revenues Below Expectatio

Piper Sandler on Tilray Q2; Canada Revenues Below Expectatio
Piper Sandler on Tilray Q2; Canada Revenues Below Expectations; EBITDA Margins Better 

MIDNIGHTTRADER - Updated 11 minutes ago 

08:21 AM EST, 01/10/2022 (MT Newswires) -- Michael Lavery over at Piper Sandler noted Monday that Tilray reported Q2 Fiscal 2022 revenues of US$155.2 million, below his $165.1M estimate and consensus of $170.5M. It reported adjusted EBITDA of $13.8M, better than its "conservative" $7.5M estimate and its eleventh consecutive quarter of positive adjusted EBITDA. Lavery noted TLRY achieved $70M in cost-savings on a run-rate basis to date and expects to exceed initial target of $80M from Aphria and Tilray synergies ahead of schedule, along with an additional $20M of synergies in F23. Tilray reported near 20% revenue growth on a year-over-year comparison to its legacy Aphria business, but was down 9.5% on a pro-forma basis. Its revenues were down near 8% sequentially. "Tilray is under intense competitive pressure in Canada, where it is making 'strategic price adjustments'; we expect that pressure to continue near-term," Lavery said.


<< Previous
Bullboard Posts
Next >>